Results 11 to 20 of about 21,426,149 (319)
Drugs in Development for Malaria [PDF]
Drugs, 2018 The last two decades have seen a surge in antimalarial drug development with product development partnerships taking a leading role. Resistance of Plasmodium falciparum to the artemisinin derivatives, piperaquine and mefloquine in Southeast Asia means new antimalarials are needed with some urgency.
Ashley, E, Phyo, A
openaire +3 more sources
Developing Drugs For Developing Countries [PDF]
Health Affairs, 2006 Infectious and parasitic diseases create enormous health burdens, but because most of the people suffering from these diseases are poor, little is invested in developing treatments. We propose that developers of treatments for neglected diseases receive a "priority review voucher." The voucher could save an average of one year of U.S.
David B, Ridley +2 more
openaire +2 more sources
Drug resistance and antiretroviral drug development [PDF]
Journal of Antimicrobial Chemotherapy, 2005 As more drugs for treating HIV have become available, drug resistance profiles within antiretroviral drug classes have become increasingly important for researchers developing new drugs and for clinicians integrating new drugs into their clinical practice. In vitro passage experiments and comprehensive phenotypic susceptibility testing are used for the
Robert W, Shafer, Jonathan M, Schapiro
openaire +2 more sources
Inter-American Development Bank Group Climate Change Action Plan 2021-2025 [PDF]
, 2021 The Climate Change Action Plan describes the IDB Groups progress since 2016 to support the regions need for low-carbon and climate-resilient development finance and its plan to raise climate ambition continuously in the region.
Inter-American Development Bank
core +1 more source
Inter-American Development Bank Sustainability Report 2019 [PDF]
, 2020 Sustainability is a core element of the IDBs work. Long-term economic growth, and the reduction of poverty and inequality in Latin America and the Caribbean depend on development that is economically, financially, environmentally, socially, and ...
Inter-American Development Bank
core +1 more source
Inter-American Development Bank Annual Report 2021: Financial Statements
, 2022 This report is the second of two volumes which together constitute the Inter-American Development Bank\u27s 2021 Annual Report. This report contains the management\u27s discussion and analysis of the Bank\u27s ordinary capital and financial ...
Inter-American Development Bank
core +1 more source
Development Effectiveness Overview (DEO) 2023
, 2023 The Development Effectiveness Overview (DEO) is an annual report produced by the IDB Group to share the results and impact of its work in Latin America and the Caribbean.
Inter-American Development Bank
core +1 more source
Drug Development: Stages of Drug Development [PDF]
Journal of Pharmacovigilance, 2015 New drug development program for the different compound is initiated because there is a disease or clinical condition without suitable pharmacotherapeutic products available. New drug development can proceed along varied pathways for different compounds.
openaire +1 more source
Drug Development in Tissue-Agnostic Indications
, 2021 A better understanding of cancer biology has led to the development of targeted therapies specifically designed to modulate an altered molecular pathway in the cancer cells or their microenvironment. Despite the identification of molecular targets across
Pauline du Rusquec +1 more
core +1 more source
Drug development, radiolabeled drugs and PET
Annals of Medicine, 1999 Positron emission tomography (PET) provides noninvasive in vivo quantitative pharmacokinetic and pharmacodynamic information on novel and established drugs. Because only very low amounts of the (potential) drug have to be administered, far below toxicity levels, human studies can be carried out even before the drug is entered in phase I studies.
Vaalburg, W +2 more
openaire +3 more sources